EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Kynurenine Pathway Metabolites as Potential Biomarkers in Chronic Pain

Andrew Auyeung, Hank C Wang, Kannan Aravagiri, Nebojsa Nick Knezevic iD

Pharmaceuticals · 02.05.2023 · 16 (5) · 681

DOI: 10.3390/ph16050681 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 02.05.2023. Verfasst von Andrew Auyeung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Advocate Illinois Masonic Medical Center, Department of Anesthesiology, Chicago, IL 60657, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pain is a pressing medical and socioeconomic issue worldwide. It is debilitating for individual patients and places a major burden on society in the forms of direct medical costs and lost work productivity. Various biochemical pathways have been explored to explain the pathophysiology of chronic pain in order to identify biomarkers that can potentially serve as both evaluators of and guides for therapeutic effectiveness. The kynurenine pathway has recently been a source of interest due to its suspected role in the development and sustainment of chronic pain conditions. The kynurenine pathway is the primary pathway responsible for the metabolization of tryptophan and generates nicotinamide adenine dinucleotide (NAD+), in addition to the metabolites kynurenine (KYN), kynurenic acid (KA), and quinolinic acid (QA). Dysregulation of this pathway and changes in the ratios of these metabolites have been associated with numerous neurotoxic and inflammatory states, many of which present simultaneously with chronic pain symptoms. While further studies utilizing biomarkers to elucidate the kynurenine pathway’s role in chronic pain are needed, the metabolites and receptors involved in its processes nevertheless present researchers with promising sources of novel and personalized disease-modifying treatments.

Schlagwörter

Stichwörter der Autor:innen

biomarkerschronic paininflammationkynurenic acidkynurenine pathwayneurotoxicityquinolinic acidtryptophan metabolism

Autor:innen und Institutionen

  • Advocate Illinois Masonic Medical Center, Department of Anesthesiology, Chicago, IL 60657, USA.
  • College of Osteopathic Medicine, Des Moines University, Des Moines, IA 50312, USA.
  • Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60064, USA.
  • Department of Anesthesiology, University of Illinois, Chicago, IL 60612, USA.
  • Department of Surgery, University of Illinois, Chicago, IL 60612, USA.

ORCID-Profile: Nebojsa Nick Knezevic

Zitieren

APA

Auyeung, A., Wang, H. C., Aravagiri, K., & Knezevic, N. N. (2023). Kynurenine Pathway Metabolites as Potential Biomarkers in Chronic Pain. Pharmaceuticals, 16(5), 681. https://doi.org/10.3390/ph16050681

Vancouver

Auyeung A, Wang HC, Aravagiri K, Knezevic NN. Kynurenine Pathway Metabolites as Potential Biomarkers in Chronic Pain. Pharmaceuticals. 2023;16(5):681. doi:10.3390/ph16050681

BibTeX
@article{Auyeung2023,
  author = {Auyeung, Andrew and Wang, Hank C and Aravagiri, Kannan and Knezevic, Nebojsa Nick},
  title = {Kynurenine Pathway Metabolites as Potential Biomarkers in Chronic Pain},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {5},
  pages = {681},
  doi = {10.3390/ph16050681}
}
Kostenlos starten →